Diem, S., Kasenda, B., Spain, L., Martin-Liberal, J., Marconcini, R., Gore, M., & Larkin, J. (2016). Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma. Br J Cancer.
Chicago Style citaatDiem, S., B. Kasenda, L. Spain, J. Martin-Liberal, R. Marconcini, M. Gore, en J. Larkin. "Serum Lactate Dehydrogenase As an Early Marker for Outcome in Patients Treated With Anti-PD-1 Therapy in Metastatic Melanoma." Br J Cancer 2016.
MLA citatieDiem, S., et al. "Serum Lactate Dehydrogenase As an Early Marker for Outcome in Patients Treated With Anti-PD-1 Therapy in Metastatic Melanoma." Br J Cancer 2016.
Let op: Deze citaties zijn niet altijd 100% accuraat.